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Characterization of Na+ transport across the cell membranes of the
ascending thin limb of Henle's loop. In the ascending thin limb of Henle's
loop (ATL), intracellular Nat is extruded by Nat/KtATPase in the
basolateral membrane. To further characterize Nat transport across the
cell membranes of the ATL, the intracellular sodium concentration
([Nat];) was monitored using a sodium-sensitive fluorescent probe, SBFI,
in the in vitro microperfused hamster ATE Basal [Nat]1 was 19.0 1.2
mM (N = 24). Removal and replacement of luminal Nat did not change[Nat]1 in the presence of Nat in the bathing fluid. In contrast, luminal
Nat removal reduced [Nat]1 from 11.6 0.9 to 6.3 0.8 m in the
absence of peritubular NC (P < 0.0005, N = 21). Replacement of luminal
Nat increased [Nat]1 to 12.6 0.9 mat In the absence of Nat in the bath,
the addition of 1 sM benzamil, 0.1 mM 5.(N,N.dimethyl)-amiloride
(DMA), 0.1 mai furosemide, or 0.1 mat trichlormethiazide to the lumen
did not change [Nat]1 or the rate of change in [Nat]; (d[Nat];/dt) after
removal and replacement of luminal Nat Decreases in luminal pH in a
Hepes-buffered solution and luminal HC03 did not affect [Nat]1. In the
absence of peritubular Nat, DMA in the bathing fluid decreased [Nat]1
from 11.4 1.3 to 6.4 1.2 mat (P C 0.01, N = 5) and completely
inhibited the changes in [Nat]; after removal and replacement of luminal
Nat. Removal of peritubular Nat reduced [Nat]; from 18.8 1.2 to 11.3
0.7 mat (P < 0.0001, N = 23). Addition of DMA in the bathing fluid
reduced [Nat]; and inhibited the changes in [Nat]; after removal and
replacement of peritubular Nat. Addition of benzamil, furosemide or
trichlormethiazide to the bathing fluid did not alter [Nat]; or the changes
in [Nat]; after removal and replacement of peritubular Nat. Decreases in
peritubular pH in a Hepes-buffered solution and peritubular HC03 did
not affect [NC]1. These results indicate that Nat transport across the cell
membranes of the ATL is mediated by the Nat/Ht antiporter in the
basolateral membrane together with Na/KATPase in the basolateral
membrane and demonstrate the absence of Nat permeability in the
luminal membrane of the ATL.
The ascending thin limb (ATL) of Henle's loop plays an
important role in the formation of concentrated urine by the
countercurrent multiplier system. It has long been debated
whether active Na absorption occurs in the ATL [1—41.
Gottshalk and Mylle [5] provided the first direct evidence for very
high permeability of Na in the hamster ATL. In 1965, Marsh and
Solomon identified the lumen-negative transepithelial voltage
(Vt) in the ATE under free-flow conditions, suggesting that Na
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was actively reabsorbed in this segment [61. Later in vivo studies
using electrodes with increased reliability found a lumen-positive
Vt under free-flow conditions in the ATE [3—71, but did not
resolve the issue of whether active Cl reabsorption was respon-
sible for lumen-positive potentials. In vitro studies demonstrated
the absence of active NaCl reabsorption in the Alt and found no
evidence for a spontaneous Vt or net reabsorption of NaCl
[8—101. As for C1 transport in the Alt, several studies have
provided substantial evidence to support the presence of a
transcellular conductive Cl transport system apparently consist-
ing of C1 channels in both the luminal and basolateral mem-
branes in the ATE [11—141. A recent study using molecular
cloning techniques revealed the presence of a Cl channel that is
highly specific for the Alt, supporting the view that cr is
passively transported across ATL cells [15]. As for the nature of
Na reabsorption in the ATE, Koyama, Yoshitomi and Imai
demonstrated the presence of protamine-sensitive Nat perme-
ability, indicating that the tight junction of the Alt is highly
permeable to Na [16]. However, they showed that only 30% of
transmural Na permeability is dependent on paracellular path-
way [16]. Therefore, their study cannot rule out the possibility that
the rest of the Na permeability might be due to the transeellular
pathway. We recently demonstrated that the hamster ATE pos-
sesses ouabain-sensitive Na/KATPase in the basolateral mem-
brane which maintains a low intracellular sodium concentration
([Na];) [17]. Although the presence of a potent Na pump
implies the presence of active Na reabsorption, our mathemat-
ical estimation of the net transport rate of Na across ATE cells
clearly indicates that ATE cell membranes are not organized
actively to reabsorb a physiologically significant amount of Nat
across the cells. We concluded that most of the NC reabsorption
in the ATE does not occur transeellularly. However, the previous
works did not exclude the possibility that several percentages of
Na reabsorption might be attributed to the transcellular pathway
(active Na reabsorption), because we observed a change in
[Na]1 in response to a change in luminal Na concentration in
the absence of peritubular Nat [17]. But, properties of Nat
transport across the cell membranes of the ATE other than
Na*fKtATPase in the basolateral membrane were not character-
ized then.
In our recent study using a pH-sensitive fluorescent probe,
BCECF, we found that a Na/H antiporter is present only in the
basolateral membrane of the ATE and that this transporter is the
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Na+(Iumen) 210 210
I 210 I Fig. 1. Representative tracing showing the effect
of removal and replacement of luminal Na + on
[Na in the A TL in the presence and absence
of bath Na. First, the tubule was bathed in and
perfused with solution A. The luminal solution
was replaced with solution B to eliminate Nat
After replacement of luminal Nat peritubular
Na was removed by replacing solution A with
solution B. Then luminal Na was again
removed and replaced. Changes in luminal Na
concentration did not change [Na]1 in the
presence of bath Nat In contrast, [Na]1
changed upon changes in luminal Na
3 mm concentration in the absence of bath Na
Table 1. Composition of artificial solutions
A B C D E F
Na mw 210.0 — 210.0 210.0 210.0
NMDG mM — 210.0 — — —
—Choline mM — — — —
C1 miw 208.0 208.0 208.0 193.0 215.5
Hepes mM 10.0 10.0 10.0 — —
HC03 miss — — — 25.0 2.5
pH 7.4 7.4 6.4 7.4 6.4
185.0
25.0
193.0
25.0
7.4
All solutions contain the following (in mM): 5.0 Kt 1.5 Ca2, 1.0 Mg2t
2.0 H2P04, 5.5 glucose, 5.0 1-alanine. Abbreviation is NMDG, N-methyl-
D(-)-glucamine. Solutions A to C were equilibrated with 100% 02.
Solutions D to F were equilibrated with 5% C02-95% 02.
main regulator of intracellular pH [18]. Because C1 transport in
the ATL is sensitive to changes in intracellular pH [12], changes in
intracellular Na activity may regulate transcellular C1 reabsorp-
tion. An understanding of the properties of Na transport across
the cell membrane is critical for the elucidation of the regulation
of C1 reabsorption, which is now considered to be one of the
most important roles of the ATL in concentrating urine.
The present study was therefore undertaken to characterize the
undefined component of Na transport across the cell mem-
branes of the ATL. The results indicate that Na transport across
the cell membrane of the ATL is conducted by the Na7H
antiporter in the basolateral membrane together with Na4!
KATPase in the basolateral membrane, and demonstrate the
absence of luminal Na permeability, that is, the absence of
transcellular Na reabsorption. Our results support the passive
theosy of the countercurrent multiplier model for concentrating
urine in the inner medulla of the kidney.
Methods
In vitro microperfusion of isolated tubules
The ATL was microdissected and microperfused in vitro on an
inverted microscope as previously described [17]. Briefly, male
golden hamsters weighing 50 to 80 g were anesthetized with an
intraperitoneal injection of 50 mg/kg of pentobarbital sodium and
the left kidneys were removed. A fragment of the ATL was
microdissected under a stereoscopic microscope with fine forceps
in a chilled dish containing N-[2-hydroxyethyl]piperazine-N'-[2-
ethanesulfonic acid] (Hepes)-buffered solution A (Table 1). The
ATL was then transferred to a perfusion chamber (2 mm in width)
mounted on the stage of an inverted microscope (IMT-2, Olym-
pus Co. Ltd., Tokyo, Japan). The distal end of the ATL with a
fragment of the medullary thick ascending limb was sucked into a
glass pipette, and the lumen of the ATL was cannulated. The ATL
was microperfused with solution A preheated at 37°C and equil-
ibrated with 100% 02. The bathing solution was continuously
exchanged at a rate of 5 ml/min to achieve complete exchange of
the solution within one second.
Measurement of intracellular Na + activity
[Na]1 was monitored using sodium-binding benzofuran isoph-
thalate (SBFI), a fluorescent probe, as previously described [17,
19]. Briefly, SBFI in the form of acetoxymethyl ester (SBFI/AM)
was loaded into the ATL cells via the tubular lumen. A 1 4id
aliquot of stock solution of SBFI/AM 40 m in DMSO was mixed
with the same amount of 25% Pluronic F-127 in DMSO and
diluted with 2 ml of solution A. This solution was then injected
into the lumen of the ATL by exchanging the luminal solution in
the perfusion pipette. After the ATL was microperfused in the
perfusion chamber at 37°C for approximately one hour, the
SBFI/AM in the lumen of the All was washed out thoroughly
with solution A. Fluorescence was measured on an inverted
microscope equipped with the OSP-3 system (Olympus Co. Ltd.,
Tokyo, Japan). The dye trapped in the cells was excited alternately
at 340 and 380 nm and the ratio of the intensities of light emitted
at 510 nm was converted to Na concentration after the back-
ground fluorescence was subtracted. Intracellular SBFI was cali-
brated at the end of each experiment using amphotericin B as
previously described [17].
Solutions
The composition of the solutions used in this study are listed in
Table 1.
Chemicals
SBFI/AM was purchased from Molecular Probes, Inc. (Eugene,
OR, USA). 5-(N,N-dimethyl)-amiloride HC1 was purchased from
Research Biochemicals, Inc. (Natick, MA, USA). Hepes, amilo-
ride and furosemide were obtained from Sigma Chemical Com-
pany (St. Louis, MO, USA). Trichlormethiazide was a gift from
Shionogi Pharmaceutical Company (Osaka, Japan). All other
lot
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Table 2. Effects of inhibitors, pH, and HC03 concentration on [Na1 in the ATL
DMA Benz FUR TCM pH 6.4 Low HC03
Lumen
C 12.6 1.5 11.2 2.1 12.3 1,4 11.5 2.2 10.5 1.5 10.9 1.4
E 12.6 0.9 10.8 1.7 12.4 1.5 11.5 2.2 10.0 1.5 10.6 1.4
Bath
C 20.2 3.6 20.0 2.1 17.9 2.1 18.7 2.2 16.0 2.4 17.4 1.8"
E 9.6 1.5 21.2 2.7 18.4 2.1 19.5 2.0 14.0 2.2 17.4 1.8"
The effects of inhibitors, pH, and HC03 concentration in the luminal solution in the absence of peritubular Na are shown under Lumen, C and
E. Tubules were bathed in solution B and perfused with solution A. Abbreviations are: DMA, 0.1 m 5-(N,N-dimethyl)-amiloride; Benz, 1 M benzamil;
FUR, 0.1 mrvi furosemide; TCM, 0.1 mi trichiormethiazide. C, control; F, experimental period. An inhibitor was added to the lumen during the
experimental period. Perfusate was replaced with solution C to acidify luminal pH to 6.4 during the experimental period.
a Tubules were bathed in solution F and perfused with solution D. Perfusate was replaced with solution E to decrease luminal HC03 concentration
during the experimental period. Results are mean SE of 6 tubules. Data are shown in ms.
The effects of inhibitors, pH, and HC03 concentration in the peritubular solution are shown under Bath, C and F. Tubules were bathed in and
perfused with solution A. An inhibitor was added to the peritubular solution during the experimental period. Bathing solution was replaced with solution
C to acidify peritubular pH to 6.4 during the experimental period.bTubules were bathed in and perfused with solution D. Bathing solution was replaced with solution E to decrease bath HC03 concentration during
the experimental period. Results are mean SE of 6 tubules (DMA, N = 5)
P < 0.05 compared with control
Results
Na transport in the luminal membrane
•0
+
z
(6) (6) (6) (6)
Fig. 2. Effects of Na transport inhibitors added to the lumen on changes in
[Na upon removal and replacement of luminal Na ÷ in the absence of
peritubular Na . Tubules were bathed in solution B and perfused with
solution A. After removal (solution B) and replacement of luminal Na±,
5-(N,N-dimethyl)-amiloride (DMA) in 0.1 mri, benzamil (Benz) in 1 1LM,
furosemide (FUR) in 0.1 mM, or trichlormethiazide (TCM) in 0.1 mM was
added to the luminal solution. After more than 5 mm, luminal Na was
again removed and replaced by using solutions B and A with an inhibitor.
The rates of change in Na] (d[Na],/dt) after removal (closed bar) and
replacement (hatched bar) of luminal Na in the presence of inhibitors
are shown as % of those without inhibitors. The number of tubules is
shown in parentheses.
chemicals were purchased from Wako Pure Chemical Industries
(Osaka, Japan).
Statistical analysis
The data were analyzed using the paired t-test. Results are
expressed as mean SE. A P value of <0.05 was accepted as
statistically significant. The rate of change in [NaI (d[Naj1Idt,
in mM/mm) was calculated from changes in [Na] in the first 30
seconds after the solution was changed.
Basal Na], in the ATL was 19.0 1.2 mrvi (N = 24). Removal
and replacement of luminal Na did not change [Na] in 6
tubules. In the absence of peritubular Nat, removal of luminal
Na decreased [Na]1 from 11.6 0.9 mat to 6.3 0.8 mat (N
21, P < 0.0005). Replacement of luminal Na increased [NaI to
12.6 0.9 mat (P < 0.0005). A representative trace is shown in
Figure 1.
The following studies examining the properties of luminal Na
transport were conducted in the absence of Na in the bath. The
addition of 0.1 mM 5-(N,N-dimethyl)-amiloride (DMA), 1 M
benzamil, 0.1 mat furosemide or 0.1 mat trichiormethiazide to the
luminal solution did not change basal [Na]1 (Table 2). In the
presence of luminal DMA, benzamil, furosemide or trichiorme-
thiazide, the rates of change in [NaI, after removal and replace-
ment of luminal Na did not differ from that of the control (Fig.
2). Ten .LM amiloride also did not affect the luminal Na transport
(data not shown). There was no significant change in [Na]
associated with decreases in luminal pH in a Hepes-buffered
solution and luminal HC03 concentration (Table 2). In contrast,
DMA in the bathing fluid significantly reduced [Na] from 11.4
1.3 to 6.4 1.2 mat (P < 0.01, N = 5) in the absence of Na in
the bath (Fig. 3A). Changes in [Na]1 after changes in luminal
Na concentration were completely inhibited by DMA in the
bath, to values that were not significantly different from zero (Fig.
3 A, B).
Na + transport in the basolateral membrane
When basolateral Na was removed, [Na]1 decreased from
18.8 1.2 m to 11.3 0.7 mat (P < 0.0001, N = 23). When Na
was added to the basolateral side of the tubules, [Na] recovered
to 20.4 1.3 m. Addition of 10 LM DMA to the bath tended to
reduce basal [Na]1 and d[NaJ1/dt, but these changes were not
significant. Addition of 0.1 mat DMA to the bath reduced [Na]
(Table 2) and inhibited the changes in [Na] after removal and
replacement of bath Na (Fig. 4). But the addition of 1 LM
benzamil, 0.1 mat furosemide or 0.1 mat trichiormethiazide to the
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Fig. 3. Effect of DMA in the peritubular solution
on [Na ], and changes in [Na upon removal
and replacement of luminal Na in the absence
of peritubular Nat A. Representative tracing. B.
Effect of peritubular DMA on d[Na]1/dt after
removal and replacement of luminal Nat Open
bar, control; hatched bar, in the presence of
peritubular DMA (N = 5). First, tubules were
bathed in solution B and perfused with solution
A. After removal (solution B) and replacement
of luminal Na, DMA in 0.1 m was added to
the peritubular solution. Then, luminal Na
was again removed and replaced.
bath did not alter [Na]1 or the rate of change in [Na] after
removal and replacement of bath Na (Table 2, Fig. 4). There was
no significant change in [Na] when either basolateral pH or
basolateral HC03 concentration was decreased (Table 2). These
results indicate that the basolateral membrane of the ATL
possesses a DMA-sensitive Na transport system but it does not
have a functional Na channel, Na-K-2Cl cotransporter,
Nat-Cl cotransporter, or HCO3-coupled Na transporters.
Discussion
The ATL plays an important role in the formation of concen-
trated urine by the countercurrent multiplier system. We have
recently identified an ouabain-sensitive Na7KATPase found
exclusively in the basolateral membrane, which maintains a low
{Na] in the hamster ATL [17]. The present study was designed
to investigate further the Na transport processes in the luminal
and basolateral membranes in this segment.
Na + transport mechanism of the luminal membrane
In our previous study, we observed a change in [Na] in
response to a change in luminal Na concentration in the absence
of peritubular Na [17]. But, as shown in the present study (Fig.
1), [Na] was not modified by changes in luminal Na concen-
tration in the presence of peritubular Nat The previous obser-
vation was consistent with but did not prove the presence of apical
Na permeability. In order to clarif' the nature of the apparent
luminal Na transport, we examined the effects of several trans-
port inhibitors. Neither amiloride, benzamil, DMA, furosemide
nor trichlormethiazide in the lumen affected [Na]1 or the rate of
change in [Na]1 (d{Na]1/dt) after removal and replacement of
luminal Nat, indicating that the luminal membrane of the ATL
does not possess a Na channel, Na/H antiporter, or Na-K-
2Cl or Na-Cl cotransporters. The absence of a Nat'H
antiporter in the luminal membrane is compatible with our recent
10—
0—
E
+
z
+
z
5 mm
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Fig. 4. Effects of Na ÷ transport inhibitors added to the bath on changes in
[Na]1 upon removal and replacement of peritubular Nat Tubules were
bathed in and perfused with solution A. After removal (solution B) and
replacement of basolateral Nat DMA in 0.1 m, Benz in 1 rtM, FUR in
0.1 m, or TCM in 0.1 mM was added to the bathing solution. After more
than 5 mi peritubular Na was again removed and replaced by using
solutions B and A with an inhibitor. d[Na]1/dt after removal (closed bar)
and replacement (hatched bar) of peritubular Na4 in the presence of
inhibitors are shown as % of those without inhibitors. < 0.005, *
0.0005.
data [18]. We examined the effect of removal of luminal C1 on
[Na1j1 and found that C1 transport was not coupled with Na4
transport in the luminal membrane (data not shown). HC03-
coupled Na4 transporters are also absent in the luminal mem-
brane, which is compatible with our recent data [181. Our prelim-
inary data using fura-2 showed the absence of a Na4ICa24
antiporter in the luminal membrane of the ATL (data not shown).
Because we were not able to obtain positive proof of the
presence of apical Na4 permeability, we examined whether a
change in [Na4]1 after a change in luminal Na4 concentration
reflected basolateral Na4 permeability. It is possible that the Na4
involved in this process came from the lumen across the paracel-
lular pathway. Surprisingly, DMA in the bath reduced [Na4]1 in
the absence of peritubular Na4 and completely inhibited the
changes in [Na]1 after changes in luminal Na4 concentration.
This result may be explained as follows. In the absence of Na4 in
the bath, luminal Na4 continuously flows out to the basolateral
side through the tight junction. Leaked Na4 then enters the cells
through basolateral DMA-sensitive Na4 transporters and in-
creases the basal [Na4]1 under these experimental conditions.
Because the permeability of the tight junction is extraordinarily
high, Na4 concentration in the basolateral microenvironment
beside the cells is partially equilibrated with that in the lumen.
Once the basolateral Na4 transporters are blocked, Na4 in the
lumen is unable to flow into the cells across the basolateral
membrane of the ATL. Then basal [Na4]1 decreases and changes
in luminal Na4 concentration no longer alter [Na4]1. It is unlikely
that DMA inhibits the apical Na4 transport pathway only from
the cytoplasmic side and that DMA enters the cells only across the
basolateral membranes, considering the following four observa-
tions: (1) amiloride exerts its inhibitory effect at the external
aspect of Na4/H4 antiporters [20—23]; (2) deletion of the cyto-
plasmic domain of the Na4/H4 antiporter preserves amiloride-
sensitive Na4/}f exchange [24]; (3) the amiloride binding site is
Fig. 5. Schematic representation of a proposed model of ion transport
pathways across the luminal and basolateral membranes and the tight
junction in hamsterATL. Na4 reabsorption occurs through a paracellular
shunt pathway. C1 reabsorption occurs through a transcellular route
mediated by the Cl channel which is inhibited by 4,4'-diisothiocyanostil-
bene-2,2'-disulfonic acid (DIDS), 4-aeetamido-4'-diisothiocyanostilbene
(SITS), 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB) and phlorctin[11]. Only the C1 channel in the basolateral membrane is sensitive to
furnsemide [11]. The luminal membrane of the ATL lacks Na perme-
ability and the basolateral membrane of the ATL possesses ouabain-
sensitive Na4/K4-ATPase [17] and a DMA-sensitive Nat/Ir antiporter,
which are the main regulators of [Na]1.
in the fourth putative transmembrane segment of the Nat'H4
antiporter protein [25]; and (4) 1 m DMA in the lumen did not
affect Na4 transport in the Alt (data not shown). In our
preliminary study, we tested the effect of protamine, a tight
junction inhibitor, on changes in [Na4]1 after changes in luminal
Na4 concentration in the absence of bath Na4. We did not
observe any effect of protamine. Koyama, Yoshitomi and Imai
demonstrated by a transmural 22Na4 flux study that protamine
inhibits 30% of the tight junction permeability [16]. Because it is
very difficult to detect only 30% of the changes in paracellular flux
by monitoring [Na4]1, protamine is not a useful tool to demon-
strate directly the role of the paracellular shunt in changes in
[Na4]1 after changes in luminal Na4 concentration. Our hypoth-
esis must be proved by complete inhibition of the tight junction by
specific substances, which are not available currently. Our present
results, however, suggest the absence of luminal Na4 permeability
in the ATL and demonstrate that a change in [Na4] after a
change in luminal Na4 concentration in the absence of bath Na4
does not indicate the presence of luminal Na4 permeability.
Rather, this reflects Na4 movement from the lumen to the
paracellular pathway, followed by uptake across the basolateral
membrane. Therefore, Na4 reabsorption occurs entirely across
the paracellular shunt pathway.
Na4 transport mechanism of the basolateral membrane
First, we examined the effects of several Na4 transport inhibi-
tors on Na4 transport across the basolateral membrane. We were
not able to add amiloride to the peritubular solution because of its
fluorescent property. In contrast, DMA in the bathing solution at
concentrations up to 0.1 mM did not show fluorescence. In the
present study, DMA blocked Na1 permeability in the basolateral
membrane by more than 90%, indicating that a DMA-sensitive
Na4 transporter plays an important role in Na4 transport across
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the cell membrane. The present studies also indicate that a Na1
channel, NaC1 cotransporter, NaK2C1 cotransporter, or HC03-
coupled Na transporters are not present in the basolateral
membrane of the ATL, implying that these transporters do not
play significant roles in Na transport across the cell membrane.
Our preliminary data using fura-2 showed the absence of a
Nat'Ca2 antiporter in the basolateral membrane of the ATL
(data not shown). Kondo, Yoshitomi and Imai demonstrated in
the in vitro microperfused hamster ATL that furosemide blocks
C1 transport exclusively from the basolateral side and that over
95% of the Cl transport in the ATL is not coupled with Na [11].
Our present data showing that furosemide did not inhibit Na
permeability in the basolateral membrane support the view that
furosemide inhibits the Cl channel in the basolateral membrane.
It is not clear why furosemide inhibits the C1 channel only in the
basolateral membrane. Further studies are required to clarify this
point. Together with our recent data, which identified a Na/H
antiporter in the basolateral membrane of the ATL as the main
regulator of intracellular pH [181, the present study indicates that
the Na/H antiporter in the basolateral membrane is not only
the main regulator of intracellular pH but also is the main
regulator of [NaJ1.
Postulated transport model of NaC1 in the ATL
Figure 5 provides a schematic representation of Na and C1
transport mechanisms in the hamster ascending thin limb of
Henle's loop based on our findings. Major components of Cl
reabsorption occur through a transcellular route. All the Na is
reabsorbed across the paracellular pathway. An amiloride-sensi-
tive Na/H antiporter and ouabain-sensitive Na/KATPase
are present in the basolateral membrane, and these are the main
[Na J, regulators.
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Appendix. Abbreviations
ATL, ascending thin limb; [Na]1, intracellular sodium concentration;
SBFI, sodium-binding benzofuran isophthalate; DMA, 5-(N,N-dimethyl)-
amiloride; BCECF, 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfiuorescein;
DMSO, dimethyl sulfoxide; Benz, benzamil; FUR, furosemide; TCM,
trichlormethiazide; d[Na]1Idt, rate of change in [Na1.
References
1. MARSH DJ, AZEN SP: Mechanism of NaC1 reabsorption by hamster
thin ascending limbs of Henle's ioop. Am J Physiol 228:71—79, 1975
2. IMAI M, Koio JP: Mechanism of sodium and chloride transport in
the thin ascending limb of Henle. J Clin Invest 58:1054—1060, 1976
3. HOGG RJ, Koiuo JP: Comparison between the electrical potential
profile and the chloride gradients in the thin limbs of Henle's loop in
rats. Kidney mt 14:428—436, 1978
4. SANDS JM, Koio JP: Countercurrent system. Kidney mt 38:695—699,
1990
5. Govrsiwj. CW, MYLLE M: Micropuncture study of the mammalian
urinary concentrating mechanism. Am J Physiol 196:927—936, 1959
6. MARSH DJ, SOLOMON S: Analysis of electrolyte movement in thin
Henle's loops of hamster papilla. Am J Physiol 208:1119—1128, 1965
7. Msi-i DJ, MARTIN CM: Origin of electrical PD's in hamster thin
ascending limbs of Henle's loop. Am J Physiol 232:F348—F357, 1977
8. IMAI M, Koiuo JP: Sodium chloride, urea, and water transport in the
thin ascending limb of Henle. Generation of osmotic gradients by
passive diffusion of solutes. J Clin Invest 53:393—402, 1974
9. Ii M: Function of the thin ascending limb of Henle of rats and
hamsters perfused in vitro. Am J Physiol 232:F201—F209, 1977
10. KONDO Y, IMAI M: Effect of glutaraldehyde on renal tubular function.
II. Selective inhibition of C1 transport in the hamster thin ascending
limb of Henle's loop. Pflugers Arch 408:484—490, 1987
11. KONDO Y, Y05HIT0MI K, IMAI M: Effects of anion transport inhibitors
and ion substitution on C1 transport in TAL of Henle's loop. Am J
Physiol 253:F1206—F1215, 1987
12. KONDO Y, Y05HITOMI K, IMA! M: Effect of pH on Cl transport in
TAL of Henle's loop. Am J Physiol 253:F1216—F1222, 1987
13. KONDO Y, YosHIToMI K, IMAI M: Effect of Ca2 on Cl transport in
thin ascending limb of Henle's loop. Am J Physiol 254:F232—F239,
1988
14. YOsHITOMI K, KONDO Y, IMAI M: Evidence for conductive C1
pathways across the cell membranes of the thin ascending limb of
Henle's loop. J Clin Invest 82:866—871, 1988
15. UCHIDA 5, Ssiu 5, FURUKAWA T, HIRAOKA M, IMAJ T, HIRATA Y,
MARUMO F: Molecular cloning of a chloride channel that is regulated
by dehydration and expressed predominantly in kidney medulla. JBiol
Chem 268:3821—3824, 1993
16. KOYAMA 5, Y05HIT0MI K, IMAI M: Effect of protamine on ion
conductance of ascending thin limb of Henle's loop from hamsters.
Am J Physiol 261:F593—F599, 1991
17. KONDO Y, ABE K, IGARA5HI Y, KUDO K, TADA K, YOSHINAGA K:
Direct evidence for the absence of active Na reabsorption in hamster
ascending thin limb of Henle's loop. J Clin Invest 91:5—11, 1993
18. FUJIWARA I, KONDO Y, IGAa.4.5HI Y, INOUE CN, TAKAHA5HI N, TADA
K, Aaa K: Amiloride-sensitive Na/H antiporter in the basolateral
membrane of hamster ascending thin limb of Henle's loop. Am J
Physiol (in press)
19. HAROOTUNIAN AT, KAo JP, ECKERT BK, T5IEN RY: Fluorescence
ratio imaging of cytosolic free Na in individual fibroblasts and
lymphocytes. J Biol Chem 264:19458—19467, 1989
20. IvEs HE, YEE VJ, WARNOCK DG: Mixed type inhibition of the renal
Nat'H antiporter by Li and amiloride. JBiol Chem 258:9710—9716,
1983
21. ARONSON PS, SUHM MA, NEE J: Interaction of external H with the
Na7H exchanger in renal microvillus membrane vesicles. J Biol
Chem 258:6767—6771, 1983
22. WARNOCK DG, REENSTRA WW, YEE VJ: Na/H antiporter of brush
border membrane vesicles: Studies with acridine orange uptake. Am J
Physiol 242:F733—F739, 1982
23. GURICH RW, WARNOCK DG: Electrically neutral NaVH exchange in
endosomes obtained from rabbit renal cortex. Am J Physiol 251 :F702—
F709, 1986
24. WAKABAYASHI S, FAFOURNOUX P, SARDET C, POUYSSEGUR J: The
Na/H antiporter cytoplasmic domain mediates growth factor sig-
nals and controls "H-sensing." Proc NatI Acad Sci USA 89:2424—
2428, 1992
25. COUNILLON L, FRANCHI A, P0UY5SEGUR J: A point mutation of the
Na47H antiporter gene (NHE1) and amplification of the mutated
allele confer amiloride resistance upon chronic acidosis. Proc Nati
Acad Sci USA 90:4508—4512, 1993
